FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Boerse Frankfurt Warrants 11:07:01 26/06/2024 pm IST | ||
| 5.09 EUR | +5.60% |
|
| Current month | -7.79% | ||
| 1 month | -6.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 5.09 | +5.60% |
| 25/24/25 | 4.82 | -4.74% |
| 24/24/24 | 5.06 | -5.24% |
| 21/24/21 | 5.34 | -0.93% |
| 20/24/20 | 5.39 | +0.37% |
Real-time Boerse Frankfurt Warrants
Last update June 26, 2024 at 11:07 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UM1ZQ8 |
| ISIN | DE000UM1ZQ81 |
| Date issued | 20/02/2024 |
| Strike | 425.7 $ |
| Maturity | Unlimited |
| Parity | 20.26 : 1 |
| Emission price | 8.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.15 € |
|---|---|
| Lowest since issue | 4.6 € |
| Spread | 0.15 € |
| Spread % | 2.84% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.8
USD
Average target price
316.4
USD
Spread / Average Target
+1.16%
- Stock Market
- Certificates
- Certificat
